65
Participants
Start Date
September 20, 2013
Primary Completion Date
January 20, 2016
Study Completion Date
January 20, 2016
Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]
The investigators shall determine all treatment regimens according to product labeling information and standard practice.
Heim Pál Children's Hospital, Department of Oncology, Budapest
Borsod-Abaúj-Zemplén County Hospital, Pediatric Dep, Miskolc
Josa Andras Egyetemi Oktatokorhaz, Department of Pediatrics, Nyíregyháza
Mohacsi Korhaz, Department of Pediatrics, Mohács
CRTH Laboratoire d'Hématologie CHRU - Hôpital du Bocage, Dijon
CHRU Purpan, CRTH - Pavillon Sénac, Toulouse
CHRU Pellegrin, Hématologie - CRTH, Bordeaux
CHU de Rennes Hôpital Pontchaillou, Rennes
Hôpital Nord, Pédiatrie, Saint-Priest-en-Jarez
American Memorial Hospital, Service de Pédiatrie, Reims
CHU de Nancy - Hôpital de Brabois- CRTH - Laboratoire Hémato-Hémostase, Vandœuvre-lès-Nancy
Universitätskliniken des Saarlandes, Klinik für pädiatrische Onkologie und Hämatologie, Homburg
Klinikum Stuttgart, Olgahospital, Pädiatrie 5, Stuttgart
Centre Hospitalier Générale, CTH, Chambéry
Leeds General Infirmary, Leeds
Birmingham Children's Hospital NHS Trust, Birmingham
Great Ormond Street Hospital for Children NHS Trust, London
Baxalta now part of Shire
INDUSTRY